Orchestra BioMed Holdings Inc. (OBIO)
NASDAQ: OBIOHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
OBIO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $340.19M
- EPS (TTM)
- -$0.86
- Dividend yield
- None
- 52-week range
- 2.66 – 6.50
- Day range
- 5.64 – 5.86
- Volume / Avg
- 241.22K / 299.73K
- Beta
- —
- Shares outstanding
- 60.11M
- Next earnings
- Nov 5, 2026
52-week range
OBIO stock today
Orchestra BioMed (OBIO) closed at $5.66 on Oct 7, down 3.08% (-$0.18), versus the S&P 500's 0.22% decline. Shares are 12.9% below their 52-week high of $6.50, set on Oct 1, 2026 and 112.6% above the 52-week low of $2.66, in the middle of the past year's range. OBIO is up 36.4% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 107.3%.
Orchestra BioMed has posted a net loss over the last twelve months (EPS of -$0.86), so its P/E ratio is not meaningful. Orchestra BioMed's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Orchestra BioMed
Company profile- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 5, 2026
Orchestra BioMed peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SNDLSNDL Inc. | 1.25 | +1.63% | $307.65M | vs OBIO |
| CGCCanopy Growth Corporation | 0.8765 | -1.59% | $393.81M | vs OBIO |
| ACBAurora Cannabis Inc. | 4.46 | -2.83% | $282.36M | vs OBIO |
| USNAUSANA Health Sciences Inc. | 14.67 | -1.08% | $271.05M | vs OBIO |
| NAGENiagen Bioscience Inc. | 2.72 | +1.12% | $215.22M | vs OBIO |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 5.13 | -0.58% | $483.46M | vs OBIO |
| MDWDMediWound Ltd. | 12.85 | -2.28% | $165.90M | vs OBIO |
| TLRYTilray Brands Inc. | 3.72 | -1.72% | $549.01M | vs OBIO |
Indexes, lists and sector
Orchestra BioMed stock FAQ
What is Orchestra BioMed's stock price today?
OBIO last traded at $5.66 as of Oct 7, 4:00 PM EDT, down 3.08% on the day. Prices are delayed at least 15 minutes.
When is Orchestra BioMed's next earnings date?
Orchestra BioMed is expected to report earnings on Thursday, November 5, 2026.
What is the OBIO 52-week high?
The 52-week high for OBIO is $6.50 and the 52-week low is $2.66. The stock is currently 12.9% below its high.